Brief: Alliance Pharma Says Dividend Remains Paused While Board Considers New Dividend Policy

Alliance Pharma

19/06/2024 07:22

June 19 (Reuters) - Alliance Pharma PLC  ALAPH.L :
    * DIVIDEND REMAINS PAUSED WHILE BOARD CONSIDERS NEW DIVIDEND
POLICY
    * GROUP PERFORMANCE IN FIVE MONTHS TO END MAY IS IN-LINE
WITH
BOARD'S EXPECTATION
    * PROFITS IN FY 2024 WILL BE IN-LINE WITH FY 2023
    * PERFORMANCE IS EXPECTED TO BE H2 WEIGHTED, PARTICULARLY IN
NIZORAL

Source text for Eikon:  ID:nRSS9591Sa 
Further company coverage:  ALAPH.L 

 ((Reuters.Briefs@thomsonreuters.com;))